Cargando…
Transdermal opioids for cancer pain
Patients with moderate to severe malignancy-related pain frequently require the use of opioid pharmacotherapy. Unfortunately, many cancer patients continue to be prescribed subtherapeutic doses of pain medications resulting in undo suffering and diminished quality of life. The choice of analgesic ph...
Autor principal: | Skaer, Tracy L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1526423/ https://www.ncbi.nlm.nih.gov/pubmed/16573839 http://dx.doi.org/10.1186/1477-7525-4-24 |
Ejemplares similares
-
Dosing considerations with transdermal formulations of fentanyl and buprenorphine for the treatment of cancer pain
por: Skaer, Tracy L
Publicado: (2014) -
Opioids Switching with Transdermal Systems in Chronic Cancer Pain
por: Aurilio, C, et al.
Publicado: (2009) -
Opioid transdermal delivery system: a useful method for pain management in children
por: Mastrangelo, Stefano, et al.
Publicado: (2021) -
Transdermal opioids for acute postoperative pain: A road less travelled!
por: Gupta, Nishkarsh, et al.
Publicado: (2022) -
Transdermal opioids for acute postoperative pain: A road less travelled!
por: Gupta, Nishkarsh, et al.
Publicado: (2023)